Skip to main content

Select Drug Profiles

Leukemia, Oncology
Ibrutinib a New Standard of Care for Elderly Patients with Chronic Lymphocytic Leukemia
Phoebe Starr
Read More
Leukemia, Oncology
Idelalisib Improves Survival When Added to Bendamustine plus Rituximab in Patients with CLL
Phoebe Starr
Read More
Leukemia, Oncology
Immunotherapy with Blinatumomab Prolongs Survival in Acute Lymphoblastic Leukemia
Chase Doyle
Read More
FDA Approvals
The Hematologic Drug Pipeline: Exciting New Treatment Options Looming
Phoebe Starr
Read More
FDA Approvals
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
Phoebe Starr
Read More
FDA Approvals
Venetoclax Shows Strong Activity in CLL
Phoebe Starr
Read More
Value-Based Care Must Be Linked to Improved Clinical Outcomes
James T. Kenney, RPh, MBA
Read More
Appendix
Read More
The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare
Laura T. Pizzi, PharmD, MPH
Read More
The Economics of Medicare Accountable Care Organizations
Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD
Stakeholder Perspective
Time to Reexamine Accountable Care Organizations?
by J. Warren Salmon, PhD
Read More
Page 118 of 244
Results 1171 - 1180 of 2434